Covered recipient · General Payments record
ANNALYSA H NGUYEN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$793.43
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $289.57 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $54.10 | 3 |
| Novo Nordisk AS | $39.07 | 2 |
| Abbott Laboratories | $36.92 | 2 |
| BECTON, DICKINSON AND COMPANY | $24.93 | 1 |
| Phadia US Inc. | $24.24 | 1 |
| Amgen Inc. | $20.48 | 1 |
| Nevro Corp. | $18.97 | 1 |
| Bausch Health US, LLC | $18.06 | 1 |
| Philips Electronics North America Corporation | $17.91 | 1 |
| Currax Pharmaceuticals LLC | $17.86 | 1 |
| Acerta Pharma LLC | $17.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.96 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124912268 | CMS |
| Abbott Laboratories | $17.96 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124912270 | CMS |
| Amgen Inc. | $20.48 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115968199 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.03 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104779958 | CMS |
| Bausch Health US, LLC | $18.06 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148026800 | CMS |
| Becton, Dickinson and Company | $24.93 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127636608 | CMS |
| Currax Pharmaceuticals LLC | $17.86 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089518206 | CMS |
| Lilly USA, LLC | $20.77 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135535364 | CMS |
| Lilly USA, LLC | $13.50 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135518226 | CMS |
| Lilly USA, LLC | $19.83 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135474908 | CMS |
| Nevro Corp. | $18.97 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130774787 | CMS |
| Novo Nordisk Inc | $17.83 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100652117 | CMS |
| Novo Nordisk Inc | $21.24 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100378049 | CMS |
| Phadia US Inc. | $24.24 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067575728 | CMS |
| Philips North America LLC | $17.91 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146921842 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.